agilon health inc
NYSE:AGL
agilon health inc
Cost of Revenue
agilon health inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
agilon health inc
NYSE:AGL
|
Cost of Revenue
$-4B
|
CAGR 3-Years
-58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cost of Revenue
$-8.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
$-6.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
$-303.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-11%
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
$-170.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
$-8.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
See Also
What is agilon health inc's Cost of Revenue?
Cost of Revenue
-4B
USD
Based on the financial report for Dec 31, 2023, agilon health inc's Cost of Revenue amounts to -4B USD.
What is agilon health inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-58%
Over the last year, the Cost of Revenue growth was -67%. The average annual Cost of Revenue growth rates for agilon health inc have been -58% over the past three years .